Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001493152-25-013010
Filing Date
2025-09-10
Accepted
2025-09-10 17:25:28
Documents
17

Document Format Files

Seq Description Document Type Size
1 S-3 forms-3.htm S-3 609270
2 EX-4.5 ex4-5.htm EX-4.5 441400
3 EX-5.1 ex5-1.htm EX-5.1 45648
4 EX-23.1 ex23-1.htm EX-23.1 6476
5 EX-FILING FEES ex107.htm   iXBRL EX-FILING FEES 105127
6 GRAPHIC forms-3_001.jpg GRAPHIC 4309
7 GRAPHIC forms-3_002.jpg GRAPHIC 4309
  Complete submission text file 0001493152-25-013010.txt   1403956

Data Files

Seq Description Document Type Size
20 EXTRACTED XBRL INSTANCE DOCUMENT ex107_htm.xml XML 19221
Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Filer) CIK: 0000715446 (see all company filings)

EIN.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
Type: S-3 | Act: 33 | File No.: 333-290178 | Film No.: 251306659
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)